Back
Biomarin Pharmaceutical Vs. Moderna Industry Stock Comparison
Buy
60
BMRN
Biomarin Pharmaceutical
Last Price:
64.25
Seasonality Move:
12.47%
Sell
9
MRNA
Moderna
Last Price:
41.12
Seasonality Move:
11.38%
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $63.45. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
9
Moderna (MRNA)
is a Sell
Is Moderna a Buy, Sell or Hold?
- The current Moderna [MRNA] share price is $38.25. The Score for MRNA is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- MRNA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $63.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.1 | Sell |
| Relative Strength Index (14 RSI): | 33.54 | Sell |
| Chaikin Money Flow: | 933432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.12 - 69.52) | Sell |
| Bollinger Bands (100): | (68.19 - 87.29) | Sell |
MRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.78 | Sell |
| Relative Strength Index (14 RSI): | 25.42 | Sell |
| Chaikin Money Flow: | 5338096 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.46 - 55.1) | Sell |
| Bollinger Bands (100): | (50.79 - 102.79) | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.96 | Sell |
| 20-day SMA: | 65.96 | Sell |
| 50-day SMA: | 68.96 | Sell |
| 200-day SMA: | 81.18 | Sell |
| 8-day EMA: | 63.79 | Sell |
| 20-day EMA: | 65.7 | Sell |
| 50-day EMA: | 69.97 | Sell |
| 200-day EMA: | 79.54 | Sell |
MRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.28 | Sell |
| 20-day SMA: | 46.98 | Sell |
| 50-day SMA: | 55.8 | Sell |
| 200-day SMA: | 96.59 | Sell |
| 8-day EMA: | 39.92 | Sell |
| 20-day EMA: | 45.38 | Sell |
| 50-day EMA: | 56.58 | Sell |
| 200-day EMA: | 87 | Sell |
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Moderna Earnings Growth & MRNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $0.49 per share.
Biomarin Pharmaceutical Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Moderna Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||